Tablets "Regulon" is applied inside 1 day of the beginning of the menstrual cycle. The drug is administered 1 tablet 1 time per day. The duration of therapy is 21 days. It is desirable that the reception occurred daily at the same time. After completing the course, you must take a break of 7 days, during which should happen bleeding that resembles menstruation. 4 weeks after taking the first pill (day 8 after the break) use of funds resumed.
After starting to use drugs, the patient did not require use of additional methods of contraception. If a woman is on the pill only for 2-5 days after the beginning of the month within 7 days you may need to use a condom or alternative method of preventing pregnancy. After 5 days of menstruation the drug should be postponed until the next cycle.
Women who have just had a child may not begin receiving funds earlier than 21 days after childbirth. In this case also need to consult your doctor before use "Regulon". If the post-Natal period the patient has had sexual contact, you should not start the course before the resumption of menstruation.
Abortion is not a contraindication for the drug use, but because in the absence of health restrictions, the woman can start taking birth control since day one. To delay monthly you can drink laid without a break of 7 days, i.e. after packing (21 day) should continue to use the usual dose of tablets.
If the patient forgot to carry the drug in the usual time, you should drink it within 12 hours, and then resume the application on schedule. After 12 hours the dose is missed and it is desirable to use additional means of contraception during sexual contact.
Among the contraindications of the "Regulon" you can celebrate hypertension (moderate and severe), hyperlipidemia, heart attack, disease of the arteries, increased risk of thromboembolic disease, disorder, severe liver disease, porphyria. You can not combine the remedy with steroid medications. It is forbidden to use birth control with estrogen-dependent tumors (for example, in some forms of breast cancer), genital bleeding, systemic lupus erythematosus, genital herpes, pregnancy, and suspected her.